CCL19 recruits immune cells, including T cells and dendritic cells, to the tumor microenvironment via CCR7 binding, while promoting their accumulation in lymph nodes and other immune activation sites (Sun et al., 2025). The gene discussed is CCR7; the disease is neoplasm.